Full Text

Turn on search term navigation

© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Background

The dynamics of mammalian follicular development and atresia is an intricate process involving the cell-cell communication mediated by secreted ovarian factors. These interactions are critical for oocyte development and regulation of follicular atresia which in part are mediated by keratinocyte growth factor (KGF) and kit ligand (KITLG), but their roles in the regulation of apoptosis in buffalo granulosa cells have not yet been defined. During mammalian follicular development, granulosa cell apoptosis triggers the atresia so ~ 1% follicles reach the ovulation stage. In the present study, we used buffalo granulosa cells to examine the effects of KGF and KITLG in apoptosis regulation and investigated potential mechanism on Fas-FasL and Bcl-2 signaling pathways.

Result

Isolated buffalo granulosa cells were cultured with KGF and KITLG proteins using different doses (0, 10, 20, and 50 ng/ml) independently or in combination. Expression analysis for both anti-apoptotic (Bcl-2, Bcl-xL, and cFLIP) and pro-apoptotic (Bax, Fas, and FasL) genes at transcriptional levels were carried out by real-time PCR. Upon treatments, expression levels of anti-apoptotic genes were significantly upregulated in a dose-dependent manner, showing an upregulation at 50 ng/ml (independently), and at 10 ng/ml in combination. Additionally, upregulation of growth-promoting factors, bFGF, and α-Inhibin was also observed.

Conclusions

Our findings suggest the potential roles of KGF and KITLG in determining granulosa cell growth and regulating apoptosis.

Details

Title
The potential role of the KFG and KITLG proteins in preventing granulosa cell apoptosis in Bubalus bubalis
Author
Panwar, Deepak 1 ; Rawal, Leena 1 ; Ali, Sher 2 

 National Institute of Immunology, Molecular Genetics Laboratory, New Delhi, India (GRID:grid.19100.39) (ISNI:0000 0001 2176 7428); Dr. Lal Pathlabs, Present Address: National Reference Laboratory, New Delhi, India (GRID:grid.19100.39) 
 National Institute of Immunology, Molecular Genetics Laboratory, New Delhi, India (GRID:grid.19100.39) (ISNI:0000 0001 2176 7428); VC Office, Era University, Present Address: Department of Personalized Medicine, Lucknow, India (GRID:grid.19100.39) 
Pages
39
Publication year
2023
Publication date
Dec 2023
Publisher
Springer Nature B.V.
ISSN
1687157X
e-ISSN
20905920
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2793287452
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.